Aspen Aerogels, Inc. (NYSE:ASPN) Sees Significant Increase in Short Interest

Aspen Aerogels, Inc. (NYSE:ASPN) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 9,820,000 shares, a growth of 9.4% from the December 31st total of 8,980,000 shares. Based on an average trading volume of 2,470,000 shares, the short-interest ratio is currently 4.0 days.

Aspen Aerogels Trading Down 0.8 %

Shares of ASPN traded down $0.09 during mid-day trading on Monday, hitting $11.60. The company had a trading volume of 1,363,386 shares, compared to its average volume of 1,529,014. Aspen Aerogels has a 1-year low of $10.67 and a 1-year high of $33.15. The business’s 50-day simple moving average is $12.82 and its 200-day simple moving average is $19.23. The stock has a market cap of $951.45 million, a PE ratio of 1,160.76 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the company. Olympiad Research LP acquired a new position in shares of Aspen Aerogels in the 4th quarter valued at about $285,000. Rice Hall James & Associates LLC raised its holdings in Aspen Aerogels by 3.6% in the fourth quarter. Rice Hall James & Associates LLC now owns 554,202 shares of the construction company’s stock valued at $6,584,000 after buying an additional 19,089 shares during the period. Rhumbline Advisers lifted its position in Aspen Aerogels by 2.8% during the fourth quarter. Rhumbline Advisers now owns 93,044 shares of the construction company’s stock valued at $1,105,000 after buying an additional 2,554 shares in the last quarter. Yorktown Management & Research Co Inc increased its position in shares of Aspen Aerogels by 105.1% in the fourth quarter. Yorktown Management & Research Co Inc now owns 44,100 shares of the construction company’s stock worth $524,000 after acquiring an additional 22,600 shares in the last quarter. Finally, Sargent Investment Group LLC raised its stake in shares of Aspen Aerogels by 14.7% in the 4th quarter. Sargent Investment Group LLC now owns 371,049 shares of the construction company’s stock valued at $4,723,000 after acquiring an additional 47,680 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

ASPN has been the subject of several recent analyst reports. HC Wainwright reiterated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, January 16th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Barclays cut their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Finally, Piper Sandler cut their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $29.11.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.